DCL.VN Cuu Long Pharmaceutical JSC

Healthcare Drug Manufacturers - Specialty & Generic Vietnam Stocks
Add to portfolio Ask AI about DCL.VN
44,000 VND
Close of Oct 30, 2026
30,800 60,900
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
0.7/5

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is DCL.VN undervalued?

Graham number

The Graham number of Cuu Long Pharmaceutical JSC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cuu Long Pharmaceutical JSC fundamental analysis

3 of 21 checks passed

ROE 0/2

ROE cannot be calculated: equity is negative or not reported.

ROA 0/1

Return on assets cannot be compared with the industry.

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Earnings growth cannot be compared with the industry.

Revenue Growth 0/2

Revenue did not grow over the past 3 years or is not reported.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (13.5%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Cash Runway 0/2

Cash runway cannot be calculated.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book is negative or not available.

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Cuu Long Pharmaceutical JSC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cuu Long Pharmaceutical JSC

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antihistamine, musculoskeletal, dermatology, analgesics and antipyretics, antibiotics, analgesics and anti-inflammatories, respiratory, gastrointestinal, cardiovascular, vitamins and minerals, and nervous medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuti…

Full company profile